MoneyWorks4Me

The sales for the June 2025 quarter moved down -61.79% to Rs. 0.81 millions as compared to Rs. 2.12 millions during the year ago period.The Net Loss for the quarter ended June 2025 is Rs. -1.74 millions as compared to Net Loss of Rs. -1.04 millions of corresponding quarter ended June 2024 Operating profit Margin for the quarter ended June 2025 further decreased to -1.62% as compared to -0.97% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 0.81 2.12 -61.79 0.81 2.12 -61.79 3.83 22.85 -83.24
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT -1.62 -0.97 67.01 -1.62 -0.97 67.01 -8.41 -63.64 -86.79
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.03 4.82 -99.38
PBDT -1.62 -0.97 67.01 -1.62 -0.97 67.01 -8.25 -68.47 -87.95
Depreciation 0.00 0.05 0.00 0.00 0.05 0.00 0.12 2.28 -94.74
PBT -1.62 -1.02 58.82 -1.62 -1.02 58.82 -8.37 -70.75 -88.17
TAX 0.12 0.02 500.00 0.12 0.02 500.00 0.09 9.66 -99.07
Deferred Tax 0.12 0.02 500.00 0.12 0.02 500.00 0.09 -3.28 -102.74
PAT -1.74 -1.04 67.31 -1.74 -1.04 67.31 -8.46 -80.41 -89.48
Equity 81.31 81.31 0.00 81.31 81.31 0.00 81.31 81.31 0.00
PBIDTM(%) -200.00 -45.75 337.11 -200.00 -45.75 337.11 -219.58 -278.51 -21.16
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..